Walleye Trading’s Japer Therapeutics Warrants JSPRW Stock Holding History
Bought
Maintained
Sold
Other funds holding JSPRW
BFM
TCM
TC
CS
IA
Walleye Trading's JSPRW Position: Q4 2025 in Review
Walleye Trading sold out of Japer Therapeutics Warrants (JSPRW) in Q4 2025, closing a stake of 34,142 shares — an estimated $2.72K sold.
Walleye Trading first reported a position in JSPRW in Q3 2020 and held it in 19 quarters. The position peaked at $60K in Q3 2021. 9 funds tracked by Wall St. Rank hold JSPRW as of Q4 2025.
- Walleye Trading reported no remaining Japer Therapeutics Warrants position as of Q4 2025 after selling out during the quarter.
- Walleye Trading sold 34,142 Japer Therapeutics Warrants shares in Q4 2025, an estimated $2.72K.
- Walleye Trading first reported a position in Japer Therapeutics Warrants in Q3 2020 and held it in 19 quarters.
- Walleye Trading's Japer Therapeutics Warrants position peaked at $60K in Q3 2021.
- 9 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q4 2025.
Based on Walleye Trading's 13F filing for Q4 2025, filed 13 Feb 2026.